Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan

Podos, S. D., Trachtman, H., Appel, G. B., Bomback, A. S., Dixon, B. P., Wetzels, J. F. M., Cook, H. T., Parikh, S. V., Pickering, M. C., Tumlin, J., Langman, C. B., Lightstone, L., Sperati, C. J., Daina, E., Bouman, K. P., Rice, K., Thanassi, J. A., Huang, M., Nester, C., & Remuzzi, G. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology, 53(10), 675–686. Portico. https://doi.org/10.1159/000527166
Authors:
Steven D. Podos
Howard Trachtman
Gerald B. Appel
Andrew S. Bomback
Bradley P. Dixon
Jack F.M. Wetzels
H. Terence Cook
Samir V. Parikh
Matthew C. Pickering
James Tumlin
Craig B. Langman
Liz Lightstone
C. John Sperati
Erica Daina
Koenraad Peter Bouman
Kara Rice
Jane A. Thanassi
Mingjun Huang
Carla Nester
Giuseppe Remuzzi
Affiliated Authors:
Gerald B. Appel
Andrew S. Bomback
Author Keywords:
c3 glomerulopathy
biomarkers
complement system
biopsy
clinical trial
Publication Type:
Article
Unique ID:
10.1159/000527166
PMID:
Publication Date:
Data Source:
Scopus

Record Created: